Hubei Kailong Chemical Group Co., Ltd.

SZSE:002783.SZ

9.22 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2023202220212020201920182017201620152014201320122011201020092008
Revenue 3,778.7583,405.9462,741.2912,010.9411,891.3721,865.211,358.95953.713890.605884.275895.939918.987785.417570.077477.138392.882
Cost of Revenue 2,748.0872,591.4862,114.0871,456.1721,199.1561,234.947855.281555.682554.394524.491533.863583.465473.305311.051239.612260.811
Gross Profit 1,030.671814.459627.204554.77692.216630.263503.67398.031336.211359.784362.075335.522312.113259.025237.526132.071
Gross Profit Ratio 0.2730.2390.2290.2760.3660.3380.3710.4170.3780.4070.4040.3650.3970.4540.4980.336
Reseach & Development Expenses 80.70966.93645.48629.97350.85940.03241.44430.0826.46924.10729.56116.7430000
General & Administrative Expenses 162.0836567.33949.21744.95839.6538.45422.20315.07716.52816.69915.20566.49763.0159.34434.351
Selling & Marketing Expenses 94.34177.2876.79156.099211.349177.387158.519137.773107.058103.45999.84197.12490.80172.65261.1940.221
SG&A 256.424142.28144.131105.316256.307217.037196.973159.976122.136119.986116.54112.329157.298135.662120.53474.572
Other Expenses -27.495247.877281.993161.915134.841-8.290.5248.1617.3574.1514.5173.022-0.2098.79318.84216.033
Operating Expenses 533.43457.093471.61297.204442.007383.571338.409256.049204.782201.782200.52178.567163.353140.986125.37177.533
Operating Income 330.33358.443103.137270.766267.468175.734173.806143.156125.155145.429152.563142.357144.065114.299100.09346.164
Operating Income Ratio 0.0870.1050.0380.1350.1410.0940.1280.150.1410.1640.170.1550.1830.20.210.118
Total Other Income Expenses Net -194.406-169.557-603.635-152.053-114.451-79.2489.0699.0150.885-8.651-4.492-12.474-4.9045.0536.7817.659
Income Before Tax 302.835188.887-500.498118.713153.017167.444174.331150.996132.314149.351157.063144.481143.856123.092118.93562.197
Income Before Tax Ratio 0.080.055-0.1830.0590.0810.090.1280.1580.1490.1690.1750.1570.1830.2160.2490.158
Income Tax Expense 55.88833.166-14.06325.14839.90335.37436.12627.45822.90229.87525.21629.60421.38719.04618.1417.785
Net Income 175.351133.332-486.43593.565113.11481.764115.013108.7897.594107.153121.612105.347106.00594.03495.30352.156
Net Income Ratio 0.0460.039-0.1770.0470.060.0440.0850.1140.110.1210.1360.1150.1350.1650.20.133
EPS 0.450.35-1.270.250.320.240.340.330.390.430.490.420.420.380.380.21
EPS Diluted 0.450.35-1.270.250.320.240.340.330.390.430.490.420.420.380.380.21
EBITDA 810.309647.57402.177465.328432.22365.992285.738229.513214.25231.181228.897217.056148.867116.361118.35357.655
EBITDA Ratio 0.2140.190.1470.2310.2290.1960.210.2410.2410.2610.2550.2360.190.2040.2480.147